Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
The Prostate|May 4, 2011
Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differencesPing Tang, Wei Du, Keji Xie, et al.Urologia Internationalis|August 28, 2012
Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissueJiefu Huang, Jinggao Fu, Hailun Zhan, et al.International Urology and Nephrology|June 11, 2011
Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated?Rubiao Ou, Chaojie Pan, Hui Chen, et al.The Journal of Spinal Cord Medicine|October 21, 2022
Intravesical injection of botulinum toxin type a may be an effective treatment option for autonomic dysreflexia in patients with high-level spinal cord injuryMaping Huang, Heyi Zheng, Tianhai Huang, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 17, 2014
MLN2238 synergizes BH3 mimetic ABT-263 in castration-resistant prostate cancer cells by induction of NOXAXinghua Wei, Ping Zhou, Xuanting Lin, et al.Medical Oncology (Northwood, London, England)|March 25, 2014
Percent free prostate-specific antigen does not improve the effectiveness of prostate cancer detection in Chinese men with a prostate-specific antigen of 2.5-20.0 ng/ml: a multicenter studyMaping Huang, Yurong Lin, Abai Xu, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2015
Plasma proteasomal chymotrypsin-like activity correlates with prostate cancer progressionXiangrong Deng, Ping Zhou, Xinghua Wei, et al.Oncology Letters|September 10, 2014
Cystitis glandularis: A controversial premalignant lesionXianlin Yi, Haoyuan Lu, Yuexian Wu, et al.Journal of Rehabilitation Medicine|August 27, 2016
Effects of botulinum toxin A injections in spinal cord injury patients with detrusor overactivity and detrusor sphincter dyssynergiaMaping Huang, Hui Chen, Chonghe Jiang, et al.Asian Journal of Urology|February 24, 2025
An open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladderZhipeng Zhang, Deyi Luo, Zhong Chen, et al.Pageof 3